https://www.fda.gov/news-events/press-announcements/fda-approves-first-biosimilar-treat-multiple-sclerosis
0
0
8/24/23 at 9:00pm
Organization
FDA.gov
Author
Office of the Commissioner
29 words
0
Comments
FDA has approved the first biosimilar to Tysabri (natalizumab) injection for the treatment of relapsing forms of multiple sclerosis.
You are the first to view
Create an account
or login to join the discussion